Why is Kwality Pharma falling/rising?

As of 24-Sep, Kwality Pharmaceuticals Ltd is currently priced at 960.00, reflecting a decrease of 11.05, or 1.14%. The stock has underperformed its sector today by 0.69%, and its delivery volume has fallen by 6.23% compared to the 5-day average, indicating a decline in investor participation. Despite this, the stock has shown strong performance over the past year, generating a return of 21.51%, significantly outpacing the broader market, which has seen negative returns of -3.77%. The company has maintained a low Debt to EBITDA ratio of 1.03 times and has reported positive results for the last six consecutive quarters, showcasing its ability to service debt effectively.
In the broader market context, the stock's short-term performance has been weaker compared to the benchmark, with a 1-week return of -2.36% against the Sensex's -1.18%. While the stock is trading at a discount compared to its peers and has attractive valuations, the recent decline in price may reflect broader market sentiments or profit-taking by investors after a strong performance over the past year. The liquidity of the stock remains adequate for trading, but the recent drop in delivery volume suggests a potential decrease in demand, which could be contributing to the current price movement.